Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.
Baker B, Bermingham IM, Leelasena I, Hickling J, Young PR, Muller DA, Forster AH. Baker B, et al. Among authors: forster ah. Vaccines (Basel). 2023 Nov 17;11(11):1725. doi: 10.3390/vaccines11111725. Vaccines (Basel). 2023. PMID: 38006057 Free PMC article.
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Forster AH, Witham K, Depelsenaire ACI, Veitch M, Wells JW, Wheatley A, Pryor M, Lickliter JD, Francis B, Rockman S, Bodle J, Treasure P, Hickling J, Fernando GJP. Forster AH, et al. PLoS Med. 2020 Mar 17;17(3):e1003024. doi: 10.1371/journal.pmed.1003024. eCollection 2020 Mar. PLoS Med. 2020. PMID: 32181756 Free PMC article. Clinical Trial.
Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
Depelsenaire ACI, Witham K, Veitch M, Wells JW, Anderson CD, Lickliter JD, Rockman S, Bodle J, Treasure P, Hickling J, Fernando GJP, Forster AH. Depelsenaire ACI, et al. Among authors: forster ah. PLoS One. 2021 Jul 30;16(7):e0255282. doi: 10.1371/journal.pone.0255282. eCollection 2021. PLoS One. 2021. PMID: 34329337 Free PMC article. Clinical Trial.
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, Davies C, Witham K, Pryor M, Bodle J, Rockman S, Frazer IH, Forster AH. Fernando GJP, et al. Among authors: forster ah. Vaccine. 2018 Jun 18;36(26):3779-3788. doi: 10.1016/j.vaccine.2018.05.053. Epub 2018 May 17. Vaccine. 2018. PMID: 29779922 Free article. Clinical Trial.
M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
Mills JS, Jayashi Flores CM, Reynolds S, Wun C, Calcutt A, Baker SB, Murugappan S, Depelsenaire ACI, Dooley J, Fahey PV, Forster AH, Pandey M, Good MF. Mills JS, et al. Among authors: forster ah. NPJ Vaccines. 2020 Aug 7;5(1):74. doi: 10.1038/s41541-020-00222-2. eCollection 2020. NPJ Vaccines. 2020. PMID: 32802413 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33574333
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
Mills JS, Jayashi Flores CM, Reynolds S, Wun C, Calcutt A, Baker SB, Murugappan S, Depelsenaire ACI, Dooley J, Fahey PV, Forster AH, Pandey M, Good MF. Mills JS, et al. Among authors: forster ah. NPJ Vaccines. 2020 Sep 3;5:80. doi: 10.1038/s41541-020-00233-z. eCollection 2020. NPJ Vaccines. 2020. PMID: 32944294 Free PMC article.
34 results